Ohmeda's first-quarter of sales decline 9%:
This article was originally published in Clinica
The BOC Group's healthcare business, Ohmeda, has seen its first-quarter sales decline 9% to £125 million ($196 million) compared with the previous year. Operating profit rose 6% to £15 million, supported by a profit on the disposal of the medical engineering systems business which supplies medical gas piping to hospitals. BOC says that during the quarter, sales of anaesthesia machines remained strong in the US while demand for equipment and devices in other markets was marginally lower than a year ago. The UK company has reported total sales for its first quarter ended December 31st, 1994, of £873.7 million, up 4%, and after-tax profit of £54.3 million compared with a loss of £34.2 million a year earlier.